These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 27995466

  • 21. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
    Ahuja BK, Jena SK, Paidi SK, Bagri S, Suresh S.
    Int J Pharm; 2015 Jan 30; 478(2):540-52. PubMed ID: 25490182
    [Abstract] [Full Text] [Related]

  • 22. Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation.
    Wang Y, Wang S, Xu Y, Wang P, Li S, Liu L, Liu M, Jin X.
    Int J Nanomedicine; 2020 Jan 30; 15():7601-7613. PubMed ID: 33116490
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate.
    Yousaf AM, Mustapha O, Kim DW, Kim DS, Kim KS, Jin SG, Yong CS, Youn YS, Oh YK, Kim JO, Choi HG.
    Int J Nanomedicine; 2016 Jan 30; 11():213-21. PubMed ID: 26834471
    [Abstract] [Full Text] [Related]

  • 25. Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability.
    Liu P, Zhou JY, Chang JH, Liu XG, Xue HF, Wang RX, Li ZS, Li CS, Wang J, Liu CZ.
    Drug Des Devel Ther; 2020 Jan 30; 14():2959-2975. PubMed ID: 32801637
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Hyperoside nanocrystals for HBV treatment: process optimization, in vitro and in vivo evaluation.
    Shen B, Wu N, Shen C, Zhang F, Wu Y, Xu P, Zhang L, Wu W, Lu Y, Han J, Wang Y, Yuan H.
    Drug Dev Ind Pharm; 2016 Nov 30; 42(11):1772-81. PubMed ID: 27032257
    [Abstract] [Full Text] [Related]

  • 29. Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent.
    Tran TH, Poudel BK, Marasini N, Chi SC, Choi HG, Yong CS, Kim JO.
    Int J Pharm; 2013 Feb 25; 443(1-2):50-7. PubMed ID: 23318367
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Design, optimization and in vitro-in vivo evaluation of smart nanocaged carrier delivery of multifunctional PEG-chitosan stabilized silybin nanocrystals.
    Liu Y, Wang Y, Zhao J.
    Int J Biol Macromol; 2019 Mar 01; 124():667-680. PubMed ID: 30502425
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods.
    Meng J, Li S, Yao Q, Zhang L, Weng Y, Cai C, Xu H, Tang X.
    Drug Dev Ind Pharm; 2014 Jul 01; 40(7):929-36. PubMed ID: 23614872
    [Abstract] [Full Text] [Related]

  • 35. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies.
    Fu Q, Sun J, Zhang D, Li M, Wang Y, Ling G, Liu X, Sun Y, Sui X, Luo C, Sun L, Han X, Lian H, Zhu M, Wang S, He Z.
    Colloids Surf B Biointerfaces; 2013 Sep 01; 109():161-6. PubMed ID: 23668980
    [Abstract] [Full Text] [Related]

  • 36. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
    Patel GV, Patel VB, Pathak A, Rajput SJ.
    Drug Dev Ind Pharm; 2014 Jan 01; 40(1):80-91. PubMed ID: 23323843
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Baicalin-berberine complex nanocrystals orally promote the co-absorption of two components.
    Li Z, Liu Y, Wang J, Feng X, Nwafor EO, Zhang Y, Liu R, Dang W, Zhang Q, Yu C, Pi J, Liu Z.
    Drug Deliv Transl Res; 2022 Dec 01; 12(12):3017-3028. PubMed ID: 35476182
    [Abstract] [Full Text] [Related]

  • 39. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.
    Yousaf AM, Kim DW, Oh YK, Yong CS, Kim JO, Choi HG.
    Int J Nanomedicine; 2015 Dec 01; 10():1819-30. PubMed ID: 25784807
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.